Donowitz GR and Earnhardt KI |
Azithromycin inhibition of intracellular Legionella micdadei. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8285604
|
Hammerschlag MR et al. |
Single dose of azithromycin for the treatment of genital chlamydial infections in adolescents. |
1993 |
J. Pediatr. |
pmid:8388950
|
Kobrehel G et al. |
9a,11-cyclic carbamates of 15-membered azalides. |
1993 |
J. Antibiot. |
pmid:8407586
|
Gordillo ME et al. |
In vitro activity of azithromycin against bacterial enteric pathogens. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8390813
|
Blais J et al. |
Inhibition of Toxoplasma gondii protein synthesis by azithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215287
|
Dever LL et al. |
Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215288
|
Heifets L et al. |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8031351
|
Fass RJ |
Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8257127
|
Lefèvre JC et al. |
In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis. |
1993 |
Pathol. Biol. |
pmid:8233628
|
Agacfidan A et al. |
In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239579
|
Tomazic J et al. |
In vivo administration of azithromycin affects lymphocyte activity in vitro. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239585
|
Cantin L and Chamberland S |
In vitro evaluation of the activities of azithromycin alone and combined with pyrimethamine against Toxoplasma gondii. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239619
|
Meyer AP et al. |
Uptake of azithromycin by human monocytes and enhanced intracellular antibacterial activity against Staphylococcus aureus. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8285612
|
Lalak NJ and Morris DL |
Azithromycin clinical pharmacokinetics. |
1993 |
Clin Pharmacokinet |
pmid:8287632
|
Saverino D et al. |
Plasmid loss from gram-negative bacteria exposed to subinhibitory concentrations of beta-lactam drugs and azithromycin. |
1993 |
New Microbiol. |
pmid:8264424
|
Pajukanta R |
In vitro antimicrobial susceptibility of Porphyromonas gingivalis to azithromycin, a novel macrolide. |
1993 |
Oral Microbiol. Immunol. |
pmid:8265209
|
Gage TW |
New drugs from 1991-1992. |
1993 |
Tex Dent J |
pmid:8273018
|
de Górgolas Hernández-Mora M et al. |
[Therapeutic approaches to cryptosporidiosis. A review of the literature]. |
1993 |
Rev Clin Esp |
pmid:8259458
|
Berger BW |
Lyme disease. |
1993 |
Semin Dermatol |
pmid:8312152
|
O'Connell S et al. |
Chronic active toxoplasmosis in an immunocompetent patient. |
1993 |
J. Infect. |
pmid:8308325
|